Dark

SMMT
Summit Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Dec 12, 2025 3:59:57 PM EST

17.56USD-2.390%(-0.43)1,591,062

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 12, 2025 9:06:30 AM EST

18.09USD+0.556%(+0.10)1,000

After-hours

Dec 12, 2025 4:00:30 PM EST

17.57USD+0.057%(+0.01)8,383

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

13.08B

Headquarters

OXFORDSHIRE, GBR

Industry

Biotechnology

Next Earnings

Mar 12, 2026 (88d)

SRPT ACER XLV

SMMT Stats

Avg. Vol. 10 Day

2,735,858

Avg. Vol. 30 Day

2,539,049

Employees

Market Cap

13,079,855,393

Shares Out.

744,442,538

On/Off Exchange

54%/46%

6 Month Beta

1.82

1 Year Beta

1.58

2 Year Beta

1.32

3 Year Beta

1.30

52 Week Low

15.55

52 Week High

36.91

SMA50

19.01

SMA200

21.95

1 Week

-4.04%

1 Month

-3.78%

3 Month

-7.23%

6 Month

-11.17%

1 Year

-1.46%

2 Year

+650.86%

5 Year

+232.77%

Profile

summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile.

SMMT Stock Summary

Summit Therapeutics Inc. Common Stock (NASDAQ:SMMT) stock price today is $17.56, and today's volume is 1,591,062. SMMT is down -2.390% today. The 30 day average volume is 2,539,049. SMMT market cap is 13.08B with 744,442,538 shares outstanding.